Orodental malformations associated with human MSX1 sequence variants.

BACKGROUND: MSX1 sequence variants have been known to cause human tooth agenesis (TA) with or without orofacial clefts. However, their roles during the whole processes of tooth development are not fully understood. This study aimed to characterize a 4-membered family with TA carrying a novel MSX1 pathogenic variant and investigate the disease mechanism. METHODS: The authors conducted whole exome analysis to define the disease-causing sequence variant. They performed microcomputed tomography, morphometric analyses, transcriptome profiling, and molecular characterization to study the affected teeth and the gene variant. RESULTS: The authors identified an MSX1 pathogenic variant, p.Glu232∗, in affected family members with TA and concomitant orodental anomalies, namely, prominent maxillary labial frenum, central incisor diastema, median maxillary anterior alveolar cleft, tooth fusion, mandibular molar dysmorphology, thin dentin layer, and slender dental roots. MSX1-defective teeth were not apparently microdontic but had thin dentin layers. The mandibular molars showed a homeotic transformation to maxillary counterparts. Genes involved in extracellular matrix organization and dentinogenesis, such as DMP1 and MMP20, were downregulated in dental pulp tissues of MSX1-defective teeth. The p.Glu232∗-truncated MSX1 properly localized to the nucleus but partially lost its transactivation ability. Analyzing reported cases indicated that truncation sequence variants within the homeobox domain of MSX1 caused a more severe TA phenotype than those outside of the homeobox domain, probably due to dominant negativity compared with haploinsufficiency. CONCLUSIONS: This study provides in vivo evidence that MSX1 contributes to developmental processes of various orodental tissues in humans. PRACTICAL IMPLICATIONS: Clinically, hypertrophic labial frenum, incisor diastema, and median maxillary anterior alveolar cleft might be considered diagnostic for MSX1-associated TA.

miR-21-5p-loaded bone mesenchymal stem cell-derived exosomes repair ovarian function in autoimmune premature ovarian insufficiency by targeting MSX1.

RESEARCH QUESTION: What is the effect of micro-RNA (miR)-21-5p-loaded bone marrow mesenchymal stem cell-derived exosomes (miR-21-Exo) on autoimmune premature ovarian insufficiency (POI)? DESIGN: The Cell Counting Kit 8 (CCK8) assay, fluorescence-activated cell sorting, western blotting, quantitative reverse transcriptase (qRT)-PCR and enzyme-linked immunosorbent assay (ELISA) verified the effect of miR-21-Exo on interferon-γ (IFN-γ)-induced KGN cells. qRT-PCR, western blotting and dual-luciferase reporter gene assays verified that miR-21-Exo mediated Msh homeobox 1 (MSX1) regulation of the Notch signalling pathway and that miR-21 interacted directly with MSX1. The effects of miR-21-Exo on the ovaries were verified by monitoring of the oestrous cycle, haematoxylin and eosin staining, follicle counts, ELISA, immunohistochemistry, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL), western blotting and qRT-PCR. RESULTS: The results showed that miR-21-Exo promoted IFN-γ-induced KGN cell proliferation and hormone synthesis, and inhibited apoptosis. Using dual-luciferase reporter gene assays, miR-21 and MSX1 were shown to have direct interactions. Moreover, the findings elucidated that miR-21-Exo inhibited cell apoptosis and promoted hormone synthesis by mediating MSX1 to regulate the Notch signalling pathway. miR-21-Exo restored the ovarian structure in a mouse model of autoimmune POI, promoted endocrine function and proliferation, and inhibited apoptosis and inflammation in vivo. CONCLUSIONS: This study demonstrates that miR-21-Exo regulates the MSX1-mediated Notch signalling pathway to inhibit granulosa cell apoptosis and improve hormone synthesis function, providing insight into a potential mechanism of molecular therapy for the treatment of autoimmune POI.

MSX1+PDGFRAlow limb mesenchyme-like cells as an efficient stem cell source for human cartilage regeneration.

Degenerative bone disorders have a significant impact on global health, and regeneration of articular cartilage remains a challenge. Existing cell therapies using mesenchymal stromal cells (MSCs) have shown limited efficacy, highlighting the necessity for alternative stem cell sources. Here, we have identified and characterized MSX1+ mesenchymal progenitor cells in the developing limb bud with remarkable osteochondral-regenerative and microenvironment-adaptive capabilities. Single-cell sequencing further revealed the presence of two major cell compositions within the MSX1+ cells, where a distinct PDGFRAlow subset retained the strongest osteochondral competency and could efficiently regenerate articular cartilage in vivo. Furthermore, a strategy was developed to generate MSX1+PDGFRAlow limb mesenchyme-like (LML) cells from human pluripotent stem cells that closely resembled their mouse counterparts, which were bipotential in vitro and could directly regenerate damaged cartilage in a mouse injury model. Together, our results indicated that MSX1+PDGFRAlow LML cells might be a prominent stem cell source for human cartilage regeneration.

Effect of MSX1 on the cellular function of cardiomyocytes.

MSX1 (Muscle Segment Homeobox 1) has pleiotropic effects in various tissues, including cardiomyocytes, while the effect of MSX1 on cardiomyocyte cellular function was not well known. In this study, we used AC16 cell culture, real-time fluorescence quantitative PCR (qPCR), protein blotting (Western blot), flow cytometry apoptosis assay and lactate dehydrogenase (LDH) ELISA (Enzyme-Linked Immunosorbnent Assay) to investigate the effect of the MSX1 gene on cardiomyocyte function. The results showed that MSX1 plays a protective role against hypoxia of cardiomyocytes. However, further studies are required to fully understand the role of MSX1 in the regulation of LDH expression in different cell types and under different conditions.

Intrahepatic homeobox protein MSX-1 is a novel host restriction factor of hepatitis B virus.

Chronic hepatitis B virus (HBV) infection (CHB) is a risk factor for the development of liver fibrosis, cirrhosis, and hepatocellular carcinoma. Covalently closed circular DNA serves as the sole transcription template for all viral RNAs and viral transcription is driven and enhanced by viral promoter and enhancer elements, respectively. Interactions between transcription factors and these cis-elements regulate their activities and change the production levels of viral RNAs. Here, we report the identification of homeobox protein MSX-1 (MSX1) as a novel host restriction factor of HBV in liver. In both HBV-transfected and HBV-infected cells, MSX1 suppresses viral gene expression and genome replication. Mechanistically, MSX1 downregulates enhancer II/core promoter (EnII/Cp) activity via direct binding to an MSX1 responsive element within EnII/Cp, and such binding competes with hepatocyte nuclear factor 4α binding to EnII/Cp due to partial overlap between their respective binding sites. Furthermore, CHB patients in immune active phase express higher levels of intrahepatic MSX1 but relatively lower levels of serum and intrahepatic HBV markers compared to those in immune tolerant phase. Finally, MSX1 was demonstrated to induce viral clearance in two mouse models of HBV persistence, suggesting possible therapeutic potential for CHB.IMPORTANCECovalently closed circular DNA plays a key role for the persistence of hepatitis B virus (HBV) since it serves as the template for viral transcription. Identification of transcription factors that regulate HBV transcription not only provides insights into molecular mechanisms of viral life cycle regulation but may also provide potential antiviral targets. In this work, we identified host MSX1 as a novel restriction factor of HBV transcription. Meanwhile, we observed higher intrahepatic MSX1 expression in chronic hepatitis B virus (CHB) patients in immune active phase compared to those in immune tolerant phase, suggesting possible involvement of MSX1 in the regulation of HBV activity by the host. Lastly, intrahepatic overexpression of MSX1 delivered by recombinant adenoviruses into two mouse models of HBV persistence demonstrated MSX1-mediated repression of HBV in vivo, and MSX1-induced clearance of intrahepatic HBV DNA in treated mice suggested its potential as a therapeutic target for the treatment of CHB.

MSX1 gene and nonsyndromic oral clefts in a Southern Brazilian population

Nonsyndromic oral clefts (NSOC) are the most common craniofacial birth defects in humans. The etiology of NSOC is complex, involving both genetic and environmental factors. Several genes that play a role in cellular proliferation, differentiation, and apoptosis have been associated with clefting. For example, variations in the homeobox gene family member MSX1, including a CA repeat located within its single intron, may play a role in clefting. The aim of this study was to investigate the association between MSX1 CA repeat polymorphism and NSOC in a Southern Brazilian population using a case-parent triad design. We studied 182 nuclear families with NSOC recruited from the Hospital de Clínicas de Porto Alegre in Southern Brazil. The polymorphic region was amplified by the polymerase chain reaction and analyzed by using an automated sequencer. Among the 182 families studied, four different alleles were observed, at frequencies of 0.057 (175 bp), 0.169 (173 bp), 0.096 (171 bp) and 0.67 (169 bp). A transmission disequilibrium test with a family-based association test (FBAT) software program was used for analysis. FBAT analysis showed overtransmission of the 169 bp allele in NSOC (P=0.0005). These results suggest that the CA repeat polymorphism of the MSX1 gene may play a role in risk of NSOC in populations from Southern Brazil.

PAX9 polymorphism and susceptibility to sporadic non-syndromic severe anodontia: a case-control study in southwest China

Our research aimed to look into the clinical traits and genetic mutations in sporadic non-syndromic anodontia and to gain insight into the role of mutations of PAX9, MSX1, AXIN2 and EDA in anodontia phenotypes, especially for the PAX9. Material and Methods The female proband and her family members from the ethnic Han families underwent complete oral examinations and received a retrospective review. Venous blood samples were obtained to screen variants in the PAX9, MSX1, AXIN2, and EDA genes. A case-control study was performed on 50 subjects with sporadic tooth agenesis (cases) and 100 healthy controls, which genotyped a PAX9 gene polymorphism (rs4904210). Results Intra-oral and panoramic radiographs revealed that the female proband had anodontia denoted by the complete absence of teeth in both the primary and secondary dentitions, while all her family members maintained normal dentitions. Detected in the female proband were variants of the PAX9 and AXIN2 including A240P (rs4904210) of the PAX9, c.148C>T (rs2240308), c.1365A>G (rs9915936) and c.1386C>T (rs1133683) of the AXIN2. The same variants were present in her unaffected younger brother. The PAX9 variations were in a different state in her parents. Mutations in the MSX1 and EDA genes were not identified. No significant diferences were found in the allele and genotype frequencies of the PAX9 polymorphism between the controls and the subjects with sporadic tooth agenesis. Conclusions These results suggest that the association of A240P with sporadic tooth agenesis still remains obscure, especially for different populations. The genotype/phenotype correlation in congenital anodontia should be verified. .

Bases moleculares de la agenesia dental no sindrómica: revisión de la información bibliográfica / Molecular bases of non-syndromic dental agenesis: a review of the literature

Este trabajo pretende actualizar los conocimientos acerca de las bases moleculares de la agenesia dental no sindrómica. Más de doscientos genes codifican múltiples proteínas con funciones necesarias para el desarrollo dental. Los factores de transcripción MSXC-1 y PAX-9 son fundamentales para activar la expresión proteica sinérgica de la cascada de señalización de las proteínas morfogénicas óseas, responsables de la progresión secuencial de la odontogénesis. En busca de las posibles causas de agenesias dentarias no sindrómicas, se han detectado dieciocho mutaciones de tipo missense de pares de dominio del gen humano PAX-9, mutaciones de haplo-insuficiencia funcional de los genes PAX-9 y MSX-1 y múltiples polimorfismos de localizaciones diversas. En todos los casos fue notable la disminución del nivel de expresión de las proteínas mutantes (a las que los genes antes mencionados codifican como transcriptores), la cual afectó la capacidad de unión al ADN de éstas. El impacto deletéreo de estas mutaciones para generar agenesias dentarias selectivas continúa siendo objeto de estudio.

Aspectos clínicos e moleculares da agenesia dentária congênita / Molecular and clinical aspects of congenital dental agenesis

A agenesia dentária consiste em uma anomalia comum de desenvolvimento, que resulta na alteração do número de dentes preentes na cavidade bucal e afeta aproximadamente 20% da população. Sua etiologia está associada a fatores ambientais, como infecções, traumas, quimioterapia, radioterapia e causas genéticas. Atualmente a etiologia mais aceita para explicar a ocorrência das anomalias dentárias é a alteração na expressão de genes específicos. Com base no conhecimento dos genes e fatores de transcrição envolvidos na odontogênese, presume-se que diferentes formas fenotípicas de agenesia dentária são causadas por mutações em diferentes genes. Os genes envolvidos na agenesia dentária em humanos incluem os fatores de transcrição (MSX1 e PAX9) que desempenham um papel crítico durante o desenvolvimento craniofacial e o gene que codifica uma proteína envolvida na via de sinalização canônica Wnt (AXIN2). Dessa maneira, a proposta do presente estudo é discorrer sobre os principais genes que têm sido relatados como reguladores da formação dental e a ocorrência de mutações nestes genes que poderiam resultar em agenesias dentárias

Dental agenesis is a common developmental anomaly which affects approximately 20% of the population and results in a reduction of number of teeth present in the oral cavity. The etiology is associated with environmental factors, such as infections, trauma, chemotherapy, radiotherapy, and genetic causes. Currently the widely accepted theory to explain the occurrence of dental agenesis is the change in the expression of specific genes. Different phenotypic patterns of dental agenesis are caused by mutations in genes and transcription factors involved in odontogenesis. In humans those genes include transcription factors (MSX1 and PAX9) that play a critical role during development and the gene coding for a protein involved in the canonical Wnt signaling (AXIN2). Therefore, the purpose of this study is to discuss about dental agenesis and the key genes that have been reported as regulators of dental formation and how the occurrence of mutations in these genes could result in dental agenesis

Análisis mutacional del gen MSX1 en pacientes con FLPNS e hipodoncia / Mutation analysis of MSX1 gene in patients with NSCLP and hypodontia

Introducción. La etiología de la hendidura labio-palatina es compleja e involucra factores genéticos y ambientales. Además de la hendidura, numerosos estudios han reportado la presencia de anomalías dentales en asociación con varias formas de hendidura labial,palatina o ambas; entre estas anomalías se ha encontrado la prevalencia de agenesia dental. La idea de que los mismos factores etiológicos que causan la formación de la hendidura afectan el desarrollo de la dentición, es apoyada por varios autores que proponen al genMSX1 como candidato para estos dos fenotipos. Una mutación nonsense (Ser104stop) en el exon 1 del gen MSX1 se encontró en una familia danesa, en la que unos miembros presentaban agenesia dental o hendidura palatina y otros presentaban las dos entidadesasociadas. A pesar de que se han realizado varios estudios sobre anomalías dentales en pacientes con hendidura labio-palatina y existen estudios que confirman a MSX1 como ungen candidato tanto para hipodoncia como para hendiduras oro-faciales, la interpretación de los resultados ha sido muy compleja. Objetivo. Determinar la presencia de la mutación reportada en pacientes colombianos con hendidura labio-palatina e hipodoncia. Materiales y métodos. Se analizaron 30 pacientes, 22 con hendidura labio-palatina y 8 sólo con hipodoncia, y 60 controles sanos, mediante exámenes clínicos y radiográficos; se les tomaron muestras de sangre por venopunción, se extrajo el ADN y se realizó amplificación por la técnica de PCR del exón 1. Posteriormente, se llevó a cabo un análisis de restricción. Resultados. De los pacientes con hendidura labio-palatina, 16 presentaron agenesias dentalesfuera y dentro del área de hendidura, la mayoría fueron laterales y premolares superiores. La mayoría de los pacientes con hipodoncia únicamente, presentaron ausencias de incisivos. Además, presentaron otras anomalías dentarias, como micrognatismo, dientes supernumerarios y prognatismo mandibular...

Introduction: The etiology of non-syndromic cleft lip palate is complex and involves genetic and environmental factors. Additional to the fissure itself, numerous studies have reported the presence of dental anomalies with various forms of cleft lip, cleft palate or both. The prevalence of dental agenesis has been found within these anomalies. The idea that the same etiology factors which cause the formation of the cleft affect the dental development is supported by various authors who propose the MSX1 gene to be the candidate for these two phenotypes. A nonsense mutation in the exon 1 of the MSX1 gene was found in a Danish family in which one of the members presented dental agenesis and/or cleft palate and others presented both entities. Although various studies have been associated reported with respect to dental anomalies in patients with nonsyndromic cleft lip palate and there are studies which confirm MSX1 as a candidate gene for hypodontia and orofacial fissures, the interpretation of the results has been very complex.Objective: To determine the presence of the mutation reported in Colombian patients with nonsyndromic cleft lip palate and hypodontia. Materials and methods: 30 patients, 22 with non-syndromic cleft lip palate and 8 with only hypodontia and 60 healthy patients were clinically and radiographically analyzed. Blood samples were taken through venopunction, the DNA was extracted and the PCR technique was utilized. Afterwords, the restriction analysiswas carried out...